| Ronald Dwayne Meador, FNP-C | |
|
6250 Us Highway 83, Abilene, TX 79606-5215 | |
| (325) 428-1100 | |
| Not Available |
| Full Name | Ronald Dwayne Meador |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 6250 Us Highway 83, Abilene, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750570545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 717493 (Texas) | Primary |
| Entity Name | Preferred Hospital Leasing Van Horn Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073579942 PECOS PAC ID: 1456381540 Enrollment ID: O20051026000398 |
News Archive
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
A symposium about "Pharmacogenomics In Dermatology And Cosmetics" will be presented on Thursday, October 8 to coincide with the 18th European Academy of Dermatology and Venereology (EADV) Congress. It will be held at the Kempinski Hotel Bristol - Salon Charlottenburg-Cecilienhof, Kurfürstendamm 27, D-10719, Berlin, Germany.
Antimicrobials Ineffective in Treating Chronic Prostatitis / Pelvic Pain Syndrome (CP/PPS): Though the traditional means of treating men with CP/PPS, use of antibiotics and alpha-adrenergic receptor blockers (tamsulosin and ciprofloxacin) did not lead to significant change after six and 12 weeks of treatment.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.
Xenon Pharmaceuticals Inc. announced today that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of PHN.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald Dwayne Meador, FNP-C Po Box 7294, Abilene, TX 79608-7294 Ph: (254) 855-6952 | Ronald Dwayne Meador, FNP-C 6250 Us Highway 83, Abilene, TX 79606-5215 Ph: (325) 428-1100 |
News Archive
South Africa's Department of Health last Thursday announced that it has allocated about $5 million this year to help achieve the goal of distributing three million female condoms in 2006, the SAPA/iafrica.com reports.
A symposium about "Pharmacogenomics In Dermatology And Cosmetics" will be presented on Thursday, October 8 to coincide with the 18th European Academy of Dermatology and Venereology (EADV) Congress. It will be held at the Kempinski Hotel Bristol - Salon Charlottenburg-Cecilienhof, Kurfürstendamm 27, D-10719, Berlin, Germany.
Antimicrobials Ineffective in Treating Chronic Prostatitis / Pelvic Pain Syndrome (CP/PPS): Though the traditional means of treating men with CP/PPS, use of antibiotics and alpha-adrenergic receptor blockers (tamsulosin and ciprofloxacin) did not lead to significant change after six and 12 weeks of treatment.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.
Xenon Pharmaceuticals Inc. announced today that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of PHN.
› Verified 1 days ago
Jewel Monique Trancoso, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2600 Ivanhoe Ln Apt 204, Abilene, TX 79605 Phone: 325-513-7293 | |
Brandon M. Goetz, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-2151 Fax: 405-321-4603 | |
Ana Maria Argumaniz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1749 Pine St, Abilene, TX 79601 Phone: 325-696-0600 | |
Lauren Brooke Terrell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 950 N 19th St Ste 200, Abilene, TX 79601 Phone: 325-670-5320 Fax: 325-670-5324 | |
Ms. Elizabeth Webber, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 818 Lexington Ave, Abilene, TX 79605 Phone: 325-696-0212 | |
Richard Sankara Musonera, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1749 Pine St, Abilene, TX 79601 Phone: 325-696-0600 Fax: 325-676-3873 | |
Bailey Ann Estes, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1210 N 18th St, Abilene, TX 79601 Phone: 325-207-4734 |